Opaleye Management Inc. - PROTEON THERAPEUTICS INC ownership

PROTEON THERAPEUTICS INC's ticker is PRTO and the CUSIP is 74371L109. A total of 18 filers reported holding PROTEON THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Opaleye Management Inc. ownership history of PROTEON THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$75,000
+435.7%
188,144
+248.4%
0.02%
+200.0%
Q3 2019$14,00054,0000.01%
Other shareholders
PROTEON THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Abingworth LLP 2,017,872$27,423,00016.02%
Monashee Investment Management LLC 77,102$1,072,0007.40%
Deer VII & Co. Ltd. 315,101$4,383,0004.15%
RA Capital Management 1,506,872$20,961,0003.01%
MPM ASSET MANAGEMENT LLC 983,381$13,679,0002.10%
Omega Fund Management, LLC 250,000$3,478,0001.96%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,265,343$17,601,0000.68%
Perceptive Advisors 550,000$7,650,0000.31%
TIVERTON ASSET MANAGEMENT LLC 375,000$5,216,0000.12%
Baker Brothers Advisors 274,617$3,820,0000.04%
View complete list of PROTEON THERAPEUTICS INC shareholders